Free Trial
CVE:LTY

Liberty Biopharma (LTY) Stock Price, News & Analysis

Liberty Biopharma logo
C$2.00 +2.00 (+∞)
As of 10/10/2018

About Liberty Biopharma Stock (CVE:LTY)

Key Stats

Today's Range
C$2.00
C$2.00
50-Day Range
C$2.00
C$2.00
52-Week Range
C$0.06
C$2.74
Volume
700 shs
Average Volume
23,286 shs
Market Capitalization
C$21.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LTY Stock News Headlines

REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
Redhill Biopharma Ltd ADR
See More Headlines

LTY Stock Analysis - Frequently Asked Questions

Liberty Biopharma's stock was trading at C$2.00 at the beginning of 2025. Since then, LTY shares have increased by 0.0% and is now trading at C$2.00.

Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liberty Biopharma investors own include Aecon Group (AEGXF), Adial Pharmaceuticals (ADIL), Adeia (ADEA), Acurx Pharmaceuticals (ACXP), AC Immune (ACIU) and Air Canada (AC).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:LTY
Previous Symbol
CVE:VVA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
8.19
Current Ratio
0.12
Quick Ratio
0.12

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.00 per share
Price / Cash Flow
2,000.00
Book Value
C$0.79 per share
Price / Book
2.53

Miscellaneous

Outstanding Shares
10,770,000
Free Float
N/A
Market Cap
C$21.54 million
Optionable
Not Optionable
Beta
N/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (CVE:LTY) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners